REFR vs VUZI vs MVIS vs WRAP vs LAZR

For growth investors, Vuzix Corporation (VUZI) is the stronger pick with 1090% revenue growth year-over-year, versus -74.

3% for MicroVision, Inc. (MVIS). Analysts rate Vuzix Corporation (VUZI) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Research Frontiers Incorporated (REFR) delivered a total return of -72.

0%, compared to -100. 0% for Luminar Technologies, Inc. (LAZR). Over 10 years, the gap is even starker: VUZI returned -30. 1% versus LAZR's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Research Frontiers Incorporated (REFR) is the lower-risk stock at 0.

78β versus Vuzix Corporation's 3. 49β — meaning VUZI is approximately 348% more volatile than REFR relative to the S&P 500. On balance sheet safety, Vuzix Corporation (VUZI) carries a lower debt/equity ratio of 4% versus 125% for Research Frontiers Incorporated — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Vuzix Corporation (VUZI) is pulling ahead at 1090% versus -74.

3% for MicroVision, Inc. (MVIS). On earnings-per-share growth, the picture is similar: Vuzix Corporation grew EPS 61. 1% year-over-year, compared to -55. 5% for Research Frontiers Incorporated. Over a 3-year CAGR, VUZI leads at 709. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Research Frontiers Incorporated (REFR) is the more profitable company, earning -182.

4% net margin versus -78. 6% for MicroVision, Inc. — meaning it keeps -182. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: REFR leads at -190. 2% versus -57. 4% for MVIS. At the gross margin level — before operating expenses — REFR leads at 83. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, VUZI (9.

3% yield), WRAP (1. 4% yield) pay a dividend. REFR, MVIS, LAZR do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Research Frontiers Incorporated (REFR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

78)). Luminar Technologies, Inc. (LAZR) carries a higher beta of 2. 40 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (REFR: -82. 1%, LAZR: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (REFR (Technology) and VUZI (Technology) and MVIS (Technology) and WRAP (Technology) and LAZR (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: REFR is a small-cap quality compounder stock; VUZI is a small-cap high-growth stock; MVIS is a small-cap quality compounder stock; WRAP is a small-cap high-growth stock; LAZR is a small-cap quality compounder stock. VUZI, WRAP pay a dividend while REFR, MVIS, LAZR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.